Krsnaa Diagnostics Ltd.

667.75 -10.40 ▼-1.5%

23 February 2024, 04:01:00 PM
Volume: 2,301

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.krsnaadiagnostics.com
Market Cap 2,156.15 Cr.
Enterprise Value(EV) 2,023.54 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 17.66 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 37.81 Trailing Twelve Months Ending 2023-12
Industry PE 71.22 Trailing Twelve Months Ending 2023-12
Book Value / Share 238.05 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.81 Calculated using Price: 667.75
Dividend Yield 0.41 Period Ending 2023-03
No. of Shares Subscribed 3.23 Cr. 32,289,763 Shares
FaceValue 5
About Krsnaa Diagnostics Ltd.
Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.

Krsnaa Diagnostics Ltd. Delivery

Delivered Qty
Traded Qty

Krsnaa Diagnostics Ltd. Performance

1 Day
-1.53%
1 Week
-3.22%
1 Month
-2.09%
3 Month
+6.20%
6 Month
+17.78%
1 Year
+73.31%
2 Year
+12.55%
5 Year
10 Year

Krsnaa Diagnostics Ltd. Fundamental Ratios

2 years 2022-03 2023-03
Return on Equity (%) 10.02 8.76
Return on Capital Employed (%) 14.47 11.75
Return on Assets (%) 7.81 6.96

Krsnaa Diagnostics Ltd. Balance Sheet

Particulars 3 years 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 684 739 755
Non Curr. Liab. 70 71 80
Curr. Liab. 121 99 241
Minority Int.
Equity & Liab. 875 909 1,076
Non Curr. Assets 541 683 644
Curr. Assets 334 226 432
Misc. Exp. not W/O
Total Assets 875 909 1,076

Krsnaa Diagnostics Ltd. Profit and Loss

Particulars 3 years 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 455 487 587
Other Income 15 19 18
Total Income 470 507 605
Total Expenditure -324 -365 -452
PBIDT 146 142 153
Interest -18 -8 -11
Depreciation -41 -54 -71
Taxation -18 -18 -14
Exceptional Items
PAT 68 62 57
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 68 62 57
Adjusted EPS 22 20 18

Krsnaa Diagnostics Ltd. Cash Flow

Particulars 2 years 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 128 76
Cash Fr. Inv. -241 -109
Cash Fr. Finan. 176 -33
Net Change 64 -66
Cash & Cash Eqvt 88 23

Krsnaa Diagnostics Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 27.38 27.38 27.38 27.80 27.80 27.80 27.80 27.80 27.03
Public 72.62 72.62 72.62 72.20 72.20 72.20 72.20 72.20 72.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Krsnaa Diagnostics Ltd. Announcements

Fri, 23 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 -Analyst / Institutional Investor Meeting scheduled to be held on February 27 2024.
Fri, 23 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 -Analyst / Institutional Investor Meeting scheduled to be held on February 26 2024.
Tue, 20 Feb 2024
Clarification For Intimation Dated February 12 2024 Bearing Reference No. KDL/SE/CI/05/2023-24
Clarification for intimation dated February 12 2024 bearing reference no. KDL/SE/CI/05/2023-24

Krsnaa Diagnostics Ltd. Technical Scans

Fri, 23 Feb 2024
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 2 Days Closing Below Previous Low for 2 Days
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Increase in 1 Year High Increase in 1 Year
CCI Oversold Zone CCI Oversold Zone

Krsnaa Diagnostics Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,560.95 +0.2%
Cipla Ltd. 118,375.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,742.15 -0.4%
Divi's Laboratories Ltd. 96,748.70 3,636.05 -0.3%
Zydus Lifesciences Ltd. 93,335.34 922.10 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,627.10 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 31.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,627.10 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 4.57 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,627.10 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,627.10 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,627.10 +0.7%

Krsnaa Diagnostics Ltd. FAQ's

What is Krsnaa Diagnostics share price?

Can I buy Krsnaa Diagnostics shares now?

What is the Dividend Yield of Krsnaa Diagnostics?

What is the Market Cap of Krsnaa Diagnostics?

What are the key metrics to analyse Krsnaa Diagnostics?

What is the 52 Week High and Low of Krsnaa Diagnostics?

What is the trend of Krsnaa Diagnostics share price?